Acute myocardial infarction: A comparison of short-term survival in national outcome registries in Sweden and the UK

The Lancet

Volumn 383, Issue 9925, 2014, Pages 1305-1312

  Chung, Sheng Chia ^a   Gedeborg, Rolf ^b   Nicholas, Owen ^a   James, Stefan ^b   Jeppsson, Anders ^c,d   Wolfe, Charles ^e,f   Heuschmann, Peter ^g   Wallentin, Lars ^b   Deanfield, John ^a   Timmis, Adam ^h   Jernberg, Tomas ⁱ   Hemingway, Harry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h BARTS HEALTH NHS TRUST   (United Kingdom)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ARTICLE; DEATH; DIABETES MELLITUS; FEMALE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; SMOKING; ST SEGMENT ELEVATION; SURVIVAL; SWEDEN; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; VERY ELDERLY; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CORONARY REPERFUSION; DISEASE REGISTRY; EVIDENCE BASED PRACTICE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART RATE; OUTCOME ASSESSMENT; SHORT TERM SURVIVAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; FEMALE; GREAT BRITAIN; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

TROPONIN;

EID: 84898049314     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62070-X     Document Type: Article

References (38)

1. Coleman MP, Forman D, Bryant H, et al, for the ICBP Module 1 Working Group. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
2. Murray CJ, Richards MA, Newton JN, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020.
3. Iglehart JK. Prioritizing comparative-effectiveness research - IOM recommendations. N Engl J Med 2009; 361: 325-28.
4. Wright RS, Anderson JL, Adams CD, et al, for the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57: e215-367
5. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-41.
6. Gavalova L. Myocardial Ischaemia National Audit Project (MINAP) 2011 report. London: National Institute for Cardiovascular Outcomes Research: 2012.
7. Jernberg T, Johanson P, Held C, Svennblad B, Lindbäck J, Wallentin L, for the SWEDEHEART/RIKS-HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011; 305: 1677-84.
8. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J, for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373-77.
9. Widimsky P, Wijns W, Fajadet J, et al, for the European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010; 31: 943-57
10. Yusuf S, Flather M, Pogue J, et al, for the OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352: 507-14.
11. Laut KG, Gale CP, Lash TL, Kristensen SD. Determinants and patterns of utilization of primary percutaneous coronary intervention across 12 European countries: 2003-2008. Int J Cardiol 2013 168: 2745-53.
12. Curry LA, Spatz E, Cherlin E, et al. What distinguishes topperforming hospitals in acute myocardial infarction mortality rates? A qualitative study. Ann Intern Med 2011; 154: 384-90.
13. White HD, Chew DP. Acute myocardial infarction. Lancet 2008; 372: 570-84.
14. Levy AR, Mitton C, Johnston KM, Harrigan B, Briggs AH. International comparison of comparative effectiveness research in five jurisdictions: insights for the US. Pharmacoeconomics 2010; 28: 813-30.
15. Schiele F, Hochadel M, Tubaro M, et al. Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J 2010; 31: 2614-24.
16. Kociol RD, Lopes RD, Clare R, et al. International variation in and factors associated with hospital readmission after myocardial infarction. JAMA 2012; 307: 66-74.
17. Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005; 26: 18-26.
18. Abildstrom SZ, Rasmussen S, Rosén M, Madsen M. Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden. Heart 2003; 89: 507-11.
19. Herrett E, Smeeth L, Walker L, Weston C, and the MINAP Academic Group. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010; 96: 1264-67.
20. Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010; 96: 1617-21.
21. Sweden National Board of Health and Welfare. National guidelines for cardiac care. http://wwwsocialstyrelsense/nationellariktlinjerforhjartsjukvard (accessed Nov 12, 2013; in Swedish).
22. The National Archives. Evaluation of the Coronary Heart Disease National Service Framework. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/ FreedomOfInformation/Freedomofinformationpublicationschemefeedback/FOIreleases/ DH-126679 (accessed Nov 12, 2013).
23. Packer C, Simpson S, Stevens A, for the EuroScan: the European Information Network on New and Changing Health Technologies. International diffusion of new health technologies: a ten-country analysis of six health technologies. Int J Technol Assess Health Care 2006; 22: 419-28.
24. Carlsson P. Health technology assessment and priority setting for health policy in Sweden. Int J Technol Assess Health Care 2004; 20: 44-54.
25. Flynn MR, Barrett C, Cosío FG, et al. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J 2005; 26: 308-13.
26. Birkhead JS, Walker L, Pearson M, Weston C, Cunningham AD, Rickards AF, for the National Audit of Myocardial Infarction Project Steering Group. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart 2004; 90: 1004-09.
27. Thygesen K, Alpert JS, White HD, for the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-38.
28. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
29. Antman EM, Anbe DT, Armstrong PW, et al, for the American College of Cardiology, and the American Heart Association Task Force on Practice Guidelines, and the Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-292.
30. Silber S, Albertsson P, Avilés FF, et al, and the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J 2005; 26: 804-47.
31. Improvement NHS. National roll-out of Primary PCI for patients with ST segment elevation myocardial infarction: an interim report (2010). http://system.improvement.nhs.uk/ImprovementSystem/ViewDocument.aspx?path= Cardiac%2FNational%2FWebsite%2FReperfusion%2FInterim%20Report%20text%20final. doc.pdf (acccessed Jan 13, 2014).
32. National Health Service. Growth of primary PCI for the treatment of heart attack patients in England 2008-2011: the role of NHS Improvement and the cardiac network, 2012. http://webarchive.nationalarchives.gov.uk/20130221101407/ http://www.improvement.nhs.uk/LinkClick.aspx?fileticket=PWttejHG45M%3D& tabid=63 (accessed Jan 13, 2014).
33. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: prehospital and in-hospital management: The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 1996; 17: 43-63.
34. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-428.
35. NICE. A prophylaxis for patients who have experienced a myocardial infarction. London: National Institute for Clinical Excellence; 2001.
36. Herrett E, Shah AD, Boggon R, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013; 346: f2350.
37. Hemingway H, Croft P, Perel P, et al, and the PROGRESS Group. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 2013; 346: e5595.
38. Denaxas SC, George J, Herrett E, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012; 41: 1625-38.